FindTrial
Sign In

Ustekinumab - Standard Dosage

BIOLOGICAL5 trials

Sponsors

Janssen Research & Development, LLC, Humanitas Clinical and Research Center, Second Affiliated Hospital of Wenzhou Medical University

Conditions

Crohn DiseaseInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Polymorphism, Single NucleotidePsoriasisUlcerative Colitis (Disorder)Ustekinumab

Phase 3

A Study of the Safety and Efficacy of Ustekinumab in Adolescent Patients With Psoriasis (CADMUS)
CompletedNCT01090427
Janssen Research & Development, LLCPsoriasis
Start: 2010-05-31End: 2014-01-31Updated: 2015-01-29

Unknown Phase

The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
RecruitingNCT06691061
Humanitas Clinical and Research CenterUlcerative Colitis (Disorder)
Start: 2023-08-01End: 2024-12-31Target: 450Updated: 2024-11-15
A Study on the Associations Between Microribonucleic Acid Gene Polymorphisms and Crohn's Disease
CompletedNCT06935929
Second Affiliated Hospital of Wenzhou Medical UniversityCrohn Disease
Start: 2020-01-01End: 2025-01-01Updated: 2025-04-20
The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
CompletedNCT06935942
Second Affiliated Hospital of Wenzhou Medical UniversityCrohn Disease
Start: 2020-01-01End: 2025-01-01Updated: 2025-04-20
The Association Between TNFSF4 Polymorphism and CD
CompletedNCT07263464
Second Affiliated Hospital of Wenzhou Medical UniversityInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis), Polymorphism, Single Nucleotide, Ustekinumab
Start: 2018-01-01End: 2025-05-31Updated: 2025-12-04

Related Papers

Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations
Pediatric Drugs2022-09-2815 citations